Latest Stories

E
Post-Earnings

Consumer Internet Stocks Q4 In Review: Electronic Arts (NASDAQ:EA) Vs Peers

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at consumer internet stocks, starting with Electronic Arts (NASDAQ:EA).

Mar 25, 2026
P
Post-Earnings

Q4 Rundown: UiPath (NYSE:PATH) Vs Other Automation Software Stocks

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the automation software industry, including UiPath (NYSE:PATH) and its peers.

Mar 25, 2026
Q
Post-Earnings

Q4 Earnings Highs And Lows: Qualcomm (NASDAQ:QCOM) Vs The Rest Of The Processors and Graphics Chips Stocks

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Qualcomm (NASDAQ:QCOM) and the rest of the processors and graphics chips stocks fared in Q4.

Mar 25, 2026
A
Post-Earnings

A Look Back at Property & Casualty Insurance Stocks’ Q4 Earnings: Allstate (NYSE:ALL) Vs The Rest Of The Pack

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Allstate (NYSE:ALL) and the best and worst performers in the property & casualty insurance industry.

Mar 25, 2026
D
Post-Earnings

Reflecting On Consumer Discretionary - Travel and Vacation Providers Stocks’ Q4 Earnings: Delta (NYSE:DAL)

Looking back on consumer discretionary - travel and vacation providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Delta (NYSE:DAL) and its peers.

Mar 25, 2026
H
Post-Earnings

Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Halozyme Therapeutics (NASDAQ:HALO) and its peers.

Mar 25, 2026
V
Post-Earnings

Q4 Rundown: Viavi Solutions (NASDAQ:VIAV) Vs Other Inspection Instruments Stocks

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the inspection instruments industry, including Viavi Solutions (NASDAQ:VIAV) and its peers.

Mar 25, 2026
C
Post-Earnings

Q4 Earnings Highlights: Caleres (NYSE:CAL) Vs The Rest Of The Consumer Discretionary - Footwear Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how consumer discretionary - footwear stocks fared in Q4, starting with Caleres (NYSE:CAL).

Mar 25, 2026
J
Post-Earnings

Q4 Earnings Highs And Lows: Jacobs Solutions (NYSE:J) Vs The Rest Of The Government & Technical Consulting Stocks

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Jacobs Solutions (NYSE:J) and the rest of the government & technical consulting stocks fared in Q4.

Mar 25, 2026
S
Post-Earnings

Q4 Earnings Outperformers: Simply Good Foods (NASDAQ:SMPL) And The Rest Of The Shelf-Stable Food Stocks

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Simply Good Foods (NASDAQ:SMPL) and its peers.

Mar 25, 2026